Biblio
Export 209 results:
[ Author
Filters: First Letter Of Last Name is L [Clear All Filters]
“Astrocytic GluN2A and GluN2B Oppose the Synaptotoxic Effects of Amyloid-β1-40 in Hippocampal Cells.”, J Alzheimers Dis, vol. 54, no. 1, pp. 135-48, 2016.
, “miR-302 Attenuates Amyloid-β-Induced Neurotoxicity through Activation of Akt Signaling.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1083-98, 2016.
, “Pyk2 is a Novel Tau Tyrosine Kinase that is Regulated by the Tyrosine Kinase Fyn.”, J Alzheimers Dis, vol. 64, no. 1, pp. 205-221, 2018.
, “The Relationship of Brain Amyloid Load and APOE Status to Regional Cortical Thinning and Cognition in the ADNI Cohort.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1269-1282, 2017.
, “Reproductive history and risk of cognitive impairment in elderly women: a cross-sectional study in eastern China.”, J Alzheimers Dis, vol. 49, no. 1, pp. 139-47, 2016.
, “Vascular Cognitive Impairment and the Gut Microbiota.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1209-1222, 2018.
, “Sirtuin 3 Mediates Tau Deacetylation.”, J Alzheimers Dis, vol. 69, no. 2, pp. 355-362, 2019.
, “Multifunctional Compound AD-35 Improves Cognitive Impairment and Attenuates the Production of TNF-α and IL-1β in an Aβ25-35-induced Rat Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1403-1417, 2017.
, “S-Adenosylmethionine Attenuates Oxidative Stress and Neuroinflammation Induced by Amyloid-β Through Modulation of Glutathione Metabolism.”, J Alzheimers Dis, vol. 58, no. 2, pp. 549-558, 2017.
, “TRPC1 Null Exacerbates Memory Deficit and Apoptosis Induced by Amyloid-β.”, J Alzheimers Dis, vol. 63, no. 2, pp. 761-772, 2018.
, “A Brief Ischemic Postconditioning Protects Against Amyloid-β Peptide Neurotoxicity by Downregulating MLK3-MKK3/6-P38MAPK Signal in Rat Hippocampus.”, J Alzheimers Dis, vol. 71, no. 2, pp. 671-684, 2019.
, “Tau Pathology Promotes the Reorganization of the Extracellular Matrix and Inhibits the Formation of Perineuronal Nets by Regulating the Expression and the Distribution of Hyaluronic Acid Synthases.”, J Alzheimers Dis, vol. 57, no. 2, pp. 395-409, 2017.
, “Age and its association with low insulin and high amyloid-β peptides in blood.”, J Alzheimers Dis, vol. 49, no. 1, pp. 129-37, 2016.
, “Greater Regional Cortical Thickness is Associated with Selective Vulnerability to Atrophy in Alzheimer's Disease, Independent of Amyloid Load and APOE Genotype.”, J Alzheimers Dis, vol. 69, no. 1, pp. 145-156, 2019.
, “Diosgenin Attenuates Lipopolysaccharide-Induced Parkinson's Disease by Inhibiting the TLR/NF-κB Pathway.”, J Alzheimers Dis, vol. 64, no. 3, pp. 943-955, 2018.
, “The Utility of the Cognitive Function Instrument (CFI) to Detect Cognitive Decline in Non-Demented Older Adults.”, J Alzheimers Dis, vol. 60, no. 2, pp. 427-437, 2017.
, “Transthyretin Suppresses Amyloid-β Secretion by Interfering with Processing of the Amyloid-β Protein Precursor.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1263-75, 2016.
, “Streptozotocin Induces Mild Cognitive Impairment at Appropriate Doses in Mice as Determined by Long-Term Potentiation and the Morris Water Maze.”, J Alzheimers Dis, vol. 54, no. 1, pp. 89-98, 2016.
, “Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.”, J Alzheimers Dis, vol. 48, no. 1, pp. 175-87, 2015.
, “Mini-Mental State Examination in Elderly Chinese: A Population-Based Normative Study.”, J Alzheimers Dis, vol. 53, no. 2, pp. 487-96, 2016.
, “Resilience of Alzheimer's Disease to COVID-19.”, J Alzheimers Dis, vol. 77, no. 1, pp. 67-73, 2020.
, “Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease.”, Neurology, vol. 76, no. 17, pp. 1485-91, 2011.
, “Assessment of the Mid-Life Demographic and Lifestyle Risk Factors of Dementia Using Data from the Framingham Heart Study Offspring Cohort.”, J Alzheimers Dis, vol. 63, no. 3, pp. 1119-1127, 2018.
, “The Effects of Gene Mutations on Default Mode Network in Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 1, pp. 327-334, 2017.
, “Serum Uric Acid May Aggravate Alzheimer's Disease Risk by Affecting Amyloidosis in Cognitively Intact Older Adults: The CABLE Study.”, J Alzheimers Dis, vol. 81, no. 1, pp. 389-401, 2021.
,